Background. Breast cancer-related lymphedema (BCRL) is a feared complication for breast cancer patients who have undergone axillary surgery. Although clinical risk factors for BCRL are defined, data are sparse regarding common exposures that might induce incident arm swelling. The goal of this study was to quantify the association between common exposures thought to be potential risk factors and the occurrence of incident arm swelling among breast cancer survivors with or at risk for BCRL. Methods. This is a prospective subanalysis of the Physical Activity and Lymphedema (PAL) trial, a randomized controlled trial of 295 breast cancer survivors. Participants reported their exposure to 30 different potential risk factors at 3 month intervals for 1 year. Incident arm swelling was defined as a C5 % increase in interlimb water volume difference between two consecutive time points. Results. Twenty-seven participants (9 %) experienced incident arm swelling and 268 patients (91 %) did not. Sauna use was the only exposure that was significantly predictive of incident arm swelling (p = 0.05). Nonwhite and nonblack participants had a significantly increased risk for experiencing incident arm swelling (p = 0.005 for both comparisons). Conclusions. In our patient cohort, many common exposures that have been reported to be risk factors did not prove to have a significant predictive relationship for incident arm swelling. This study supports the recommendation that breast cancer patients who have had axillary surgery should avoid sauna use. The results do not confirm the need for other restrictions that may interfere with the quality of life in women with breast cancer.
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Lymphedema is a chronic condition that results when inadequate lymphatic drainage leads to the accumulation of protein-rich fluid in the interstitial space. Lymphedema is characterized by progressive swelling that has an adverse effect on quality of life and increases utilization of healthcare resources. 1 All breast cancer patients who undergo surgical treatment in the axilla (axillary lymph node dissection and sentinel lymph node biopsy) are at risk for the development of breast cancer-related lymphedema (BCRL). The incidence of BCRL varies in the literature from 7 to 30 % depending on the definition of BCRL used, the type of surgery performed, and the length of followup. [2] [3] [4] Numerous studies have been published in an attempt to determine risk factors for developing BCRL and preventive strategies to minimize the development of BCRL. [4] [5] [6] [7] [8] [9] [10] [11] Clinically related risk factors, such as the type of surgery and adjuvant treatment, are the most commonly studied causes of BCRL because they are easiest to ascertain and are not subject to patient interpretation. Many of the studies that have tried to elucidate prevention strategies are small, retrospective, single-institution reports, making it difficult to draw definitive conclusions. No definitive associations have been established between potentially high-risk, modifiable behaviors and lymphedema onset or worsening. This deficit is problematic because, confronted with an information void, non-evidence-based recommendations proliferate, and patients may engage in needless and potentially harmful avoidance behaviors. 11 One such example is the recommendation to avoid weight-lifting exercise. This recommendation has been challenged now that weight lifting among breast cancer survivors has been demonstrated to be safe, and to reduce the severity of selfreported lymphedema symptoms among breast cancer survivors. 10, 12 The primary goal of the current study was to quantify the association between common exposures and the occurrence of incident arm swelling. The secondary goals were to estimate the frequency of common exposures hypothesized to be associated with incident arm swelling as well as the frequency of incident arm swelling in a 1 year period in our patient cohort.
METHODS

Study Participants
This study is a prospective subanalysis of the Physical Activity and Lymphedema (PAL) trial, a randomized, controlled trial of 295 breast cancer survivors who were at risk for developing BCRL (n = 154) or who had stable BCRL (n = 141). 9, 10, 13 Participants with stable BCRL were 1-15 years after breast cancer diagnosis, and participants at risk for BCRL were 1-5 years after breast cancer diagnosis. Among participants with BCRL, for the purposes of the study, BCRL was defined as C10 % interlimb difference, or meeting any of the common toxicity criteria, version 3.0, for BCRL (swelling, obscuration, pitting) or a prior clinical diagnosis of BCRL. 13, 14 In addition, participants with BCRL were ineligible if they had any of the following: (1) intensive BCRL therapy within the past 3 months; (2) a recorded 10 % change in volume or circumference of the arm that lasted for C7 days in the past 3 months; (3) more than one BCRL-related infection that required antibiotics in the past 3 months; or (4) a BCRL exacerbation that resulted in a change in activities of daily living within the past 3 months. 13 The patient cohort was recruited between October 2005 and February 2007. The University of Pennsylvania institutional review board approved the study protocol, and informed consent was obtained from all participants.
Participants in the PAL trial were randomized to a progressive weight-lifting intervention versus no exercise. The primary aim of the PAL trial was to assess change in BCRL outcomes resulting from twice-weekly weight lifting among breast cancer survivors. 13 The primary outcomes and detailed methods of the PAL trial have been reported previously. 9, 10, 13 All participants were required to attend a 1-hour educational lecture entitled the ''Lymphedema Education Session,'' which was based on material from the National Lymphedema Network (NLN). [15] [16] [17] [18] Demographic characteristics, cancer treatment, and medication history were obtained by self-report. Cancer staging was taken from the state cancer registries, surgical pathology reports, or self-report. The number of lymph nodes removed was obtained from surgical pathology reports. All participants with BCRL in the PAL trial were provided with a compression sleeve to wear throughout the study. Compression sleeve adherence was assessed using a self-report measure with four categories of adherence:\25, 25-49, 50-74, or C75 %. This questionnaire was completed at baseline and at 3, 6, and 12 months, then the values averaged over 1 year.
Incident Arm Swelling Questionnaire
Participants were asked to report their exposure to 30 different potential risk factors. The list of exposures was compiled by a physical medicine and rehabilitation physician expert in lymphedema. Though nonvalidated, the questionnaire's strong face validity was attested during review by therapists treating a high volume of patients with lymphedema. The questionnaire was administered at the time of entry into the study, and again at 3, 6, and 12 months. Patients were queried about exposure to any of the risk factors encountered in the time interval since the last study visit.
Objective Measures of Arm Volume
Participants completed water volume displacement measures to assess arm volume at baseline and at 3, 6, and 12 months by blinded study staff. 16 Water volume is accurate by raters to 1 %. 19 For the purpose of this analysis, incident arm swelling was diagnosed if there was an interlimb volume of difference of C5 % accompanied by a C5 % increase in the interlimb difference when compared to the last measurement time point. This method of calculation differed from previous analyses in that we compared arm volume to the most recent previous arm volume rather than to baseline arm volume. We used the modified calculation of arm volume to isolate the change in arm volume percentage over each time interval to align with the data captured in the exposure questionnaire. Therefore, the frequency of incident arm swelling we report here is different from our primary outcome analysis reports.
9,10
Statistical Analysis
Descriptive statistics reported for baseline variables include rates for categorical variables and means or medians and standard deviations for continuous variables. Baseline characteristics of women who did and did not experience incident arm swelling were compared by nonparametric methods that included Fisher's exact test for categorical variables and the Kruskal-Wallis test for continuous variables. Mixed models were utilized for the longitudinal analysis of data to estimate the odds ratios of experiencing incident arm swelling and 95 % confidence intervals over the three time points of interest. Model fit was assessed using the Akaike and Bayesian information criterion methods. Sensitivity analysis was conducted by generalized estimating equations with exchangeable and autoregressive correlation matrices; the study findings and conclusions did not differ among methods. Additional subgroup analysis was conducted between breast cancer survivors with BCRL and those at risk, and the results did not differ between groups. Two-sided statistical significance was p B 0.05. All statistical analyses were performed with Stata SE 12.0 software (Stata, College Station, TX). Table 1 lists baseline demographic characteristics of all 295 participants. Participants were aged 36-80 (mean 56) years at baseline. Table 2 Over the 12 month study period, 27 participants (9 %) had incident arm swelling as we defined it for this study. No participant experienced more than one episode of incident arm swelling while in the study. Participants who experienced incident arm swelling differed statistically from participants without incident arm swelling with respect to race (p = 0.01), number of lymph nodes removed (p = 0.05), and treatment with radiation (p = 0.005) (Tables 1, 2) . Figure 1 and Table 3 summarize the frequency of the 30 exposures for the entire cohort. The median number of exposures for each participant at each time point was 4. The prevalence of exposures varied from \1 % for acupuncture to [75 % for lying on the affected arm.
RESULTS
In univariate mixed model analysis, sauna use (n = 13, odds ratio 5.77, 95 % confidence interval 1.00-33.82, p = 0.05) was the only exposure associated with incident arm swelling that reached statistical significance (Table 3) . In multivariate analysis, sauna use remained significantly associated with incident arm swelling (odds ratio 6.67, 95 % confidence interval 1.36-32.56, p = 0.01) ( Table 4) . There was a significant interaction between sauna use and having a cut on the affected arm that was associated with an increased risk of incident arm swelling (odds ratio 18.74, 95 % confidence interval 1.41-249.48, p = 0.027). In post hoc exploratory analysis, a pattern was identified relating to the risk of incident arm swelling and race. Fourteen participants in the study were classified as other race. Five (36 %) of 14 participants experienced incident arm swelling; this represents a 5.7-fold increase in risk for incident arm swelling compared to white and black participants. Three (50 %) of the 6 Asian participants in the study had incident arm swelling, as did all of the Pacific Islander participants.
DISCUSSION
This study evaluated the relationship between common exposures and incident arm swelling in women who have undergone axillary surgery for the treatment of breast cancer. Data pertaining to common exposures that may be related to BCRL are limited and inconclusive. This makes it difficult to give breast cancer patients definitive recommendations for risk reduction strategies. Of the 30 exposures asked about in this study, only sauna use proved to be a significant predictive factor for incident arm swelling. Multiple other exposures that are commonly considered risk-factors and are part of the NLN guidelines for risk reduction were not associated with incident arm swelling in our study cohort. [15] [16] [17] [18] The most consistently reported clinical risk factors found to be associated with BCRL are the number of nodes removed during surgery, the use of adjuvant chemotherapy and radiotherapy, pathologic nodal status, and the BMI of the patient. 1, [4] [5] [6] 8, [20] [21] [22] Although this study was not designed to evaluate clinical risk factors, we did find that the number of nodes removed (p = 0.05) and use of radiation (p = 0.005) were significantly associated with incident arm swelling. In our study, BMI was not a significant predictor for incident arm swelling (p = 0.74). Although clinicians treating women with breast cancer do consider these clinical risk factors when formulating treatment plans, they are usually not modifiable.
Demographic-related risk factors are rarely reported to be associated with increased risk of BCRL. In post hoc analysis, we found a relationship between Asian race and increased risk for incident arm swelling. Data are sparse regarding the association between race and BCRL. In a prospective cohort study of breast cancer patients, Kwan et al. 7 reported an increased risk of BCRL in black women when compared to other races. In a study that focused on risk factors for lymphedema in black and white women, Meeske et al. 8 did not find that race was associated with an increased risk for BCRL. The authors did find that BCRL was associated with modifiable factors such as hypertension and obesity. The possible association between demographic variables such as race and the development of a BCRL flare warrants further investigation.
Most lifestyle-related risk factors for BCRL are elusive and hard to relate directly to the diagnosis of incident arm swelling. In this prospective study, we were able to obtain patient data pertaining to potential exposures at multiple time points and then to correlate this information precisely with documented arm measurements. Sauna use was the only exposure that was significantly associated with incident arm swelling in our patient cohort. In the current recommendations for the prevention of lymphedema, both the NLN and the Lymphedema Framework advise patients to avoid prolonged exposure to heat in hot tubs and saunas. 17, 23 There is little evidence-based literature for these recommendations; they are mostly based on clinical experience and the concept that heat may increase blood flow to the arm and subsequently increase the load on the lymphatic system. 24 In a 2011 review of preventive measures for lymphedema, Cemal et al. concluded that there are insufficient data to recommend avoidance of extreme temperatures. 11, [25] [26] [27] Although only a small number of the participants in our study reported sauna use (n = 13), the significant association found between sauna use and incident arm swelling is worth acknowledgment and future investigation. We also found a significant interaction between sauna use and having a cut on the affected arm that was associated with an increased risk of incident arm swelling. We recommend that women with or at risk for developing BCRL avoid sauna use.
The null findings with regard to potential exposures and BCRL are as relevant as the positive associations. The participants in this study were asked about 30 different exposures that have all been hypothesized to be associated with BCRL. The data to support the avoidance of ipsilateral needlesticks are conflicting. In a 2005 prospective observational study of 188 breast cancer patients, Clark reported a significant relationship between needlesticks and BCRL and concluded that needlesticks significantly increased the risk of developing BCRL; 44 % of patients who had needlesticks developed lymphedema compared to 18 % of those without needlesticks. 4 Of note, the authors did not comment on the timing between needlestick and the development of BCRL in their cohort. In contrast, in a 2010 self-reported questionnaire study, 88 patients reported having had intravenous procedures in the affected limb, and only 4 patients (4 %) developed lymphedema presumed to be in relation to venipuncture. 28 In our cohort, 17 individual participants reported having venipuncture. One participant reported three, five participants reported two, and 11 participants reported one venipuncture procedure while in the 1 year study, respectively. Our study did not support an association between needlesticks and the development of incident arm swelling, and we therefore cannot conclude that venipuncture increases risk for the development of incident arm swelling.
An infection in the ipsilateral extremity is another patient-related exposure that has been theorized to be associated with BCRL. In a retrospective study of 923 breast cancer patients treated with axillary lymph node dissection and followed for 20 years, Petrek et al. 29 reported that arm infection was associated with the onset and clinical course of lymphedema. In addition, a 2006 case-control study reported a significant relationship between arm infection and the diagnosis of BCRL; 2 % of the controls and 37 % of patients with BCRL reportedly had an arm infection. 6 In contrast, arm infection was not associated with incident arm swelling in a study by Querci della Rovere et al. 30 and in our study. Recommendations to avoid limb constriction are pervasive but are based on limited scientific evidence. Those in support of this risk hypothesize that blood pressure monitoring can increase pressure in the limb, resulting in increased lymph production, fibrosis, and stenosis of the lymphatic vessels. 31, 32 The results of our study do not support the recommendation to avoid blood pressure measurement. Other groups have also challenged this recommendation, stating that limb compression is often used in the management of lymphedema. 33 This study is novel in that it is a prospective analysis of a large cohort of breast cancer patients in whom exposure to various potential BCRL triggers was monitored. Incident arm swelling was diagnosed in a consistent and validated manner that did not rely on patient report of arm symptoms. The study does have weaknesses. The major limitation of this study is the lack of information relating to the type of radiation and surgery the participants received as treatment for their breast cancer. The patient cohort is not necessarily generalizable to all breast cancer patients because the participants were physically and psychologically able to tolerate a 1 year exercise program. In addition, all participants received a custom-fitted compression garment to wear and attended a lymphedema education session. These resources may have increased BCRL awareness and management relative to patients who were not in this trial. The results of the questionnaires are subject to recall bias, although recall bias has been shown to be an acceptable risk in short-term studies. 34 Because of the rarity of some of the events and participants' preconceived ideas of risk factors to avoid, some of the exposures queried about in this study were experienced by small numbers of the participants, and subsequent limited statistical power to detect associations between the exposures of interest and incident arm swelling. Randomized controlled trials designed to examine many of these exposures are not possible, and this study provides useful insights into the effects of these exposures.
Future work with long-term follow-up (i.e., C3 years) will be helpful to clarify the common exposures associated with the development of BCRL. This study supports the recommendation that breast cancer patients who have had axillary surgery should avoid sauna use. The results do not confirm the need for other restrictions that may interfere with the quality of life in women with breast cancer.
